Who's doing what on EMA call for generics suspension after Indian CRO data manipulation

The European Commission says that "within roughly a month" it will make its decision on the European Medicines Agency's recommendation that hundreds of formulations and strengths of generic medicines whose European marketing authorizations relied on clinical studies performed by Indian contract research organization GVK Biosciences be suspended in the EU1.